Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes

Maxim A Moroz1, Hanwen Zhang1, Jason Lee2

  • 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

Abstract

Insights

The human norepinephrine transporter (hNET)/meta-(18)F-fluorobenzylguanidine ((18)F-MFBG) PET reporter system is the most sensitive for tracking T cells in vivo. This system can detect as few as 35-40 × 10^3 T cells, aiding adoptive T cell therapy monitoring.

Area of Science:

  • Biomedical imaging
  • Molecular biology
  • Immunotherapy

Background:

  • Monitoring genetically modified T cells is crucial for adoptive T cell therapy.
  • Sensitive reporter systems are needed to visualize T cell trafficking, proliferation, and survival without causing immune responses.
  • Human reporter gene systems are being developed for clinical translation.

Purpose of the Study:

  • To evaluate the sensitivity of different human reporter gene systems for in vivo T cell imaging.
  • To determine the minimum number of T cells detectable by various nuclear reporter systems.
  • To compare the efficacy of reporter gene-reporter probe combinations for T cell detection.

Main Methods:

  • Human T cells were transduced with reporter genes: hNET, hNIS, hdCKDM, and hsvTK.
  • Reporter T cells (10^5 to 3 × 10^6) were injected subcutaneously.
  • PET or SPECT imaging was performed after injecting radiolabeled probes.
  • T cell detection limits were determined for each system.

Main Results:

  • Transduction did not affect T cell viability or growth.
  • The hNET/(18)F-MFBG system detected <1 × 10^5 T cells with high uptake and low background.
  • The hNIS/(124)I-iodide system detected ~1 × 10^6 T cells with time-dependent uptake and high background.
  • The hdCKDM/(18)F-FEAU and hsvTK/(18)F-FEAU systems detected ~3 × 10^5 T cells.
  • (18)F-FEAU was a more efficient probe than (124)I-iodouracil derivatives.

Conclusions:

  • The hNET/(18)F-MFBG PET reporter system demonstrated the highest sensitivity.
  • This system can detect approximately 35-40 × 10^3 T cells at the injection site.
  • The hNET/(18)F-MFBG system shows significant potential for monitoring T cell-based therapies.